1. Home
  2. SANW vs CNSP Comparison

SANW vs CNSP Comparison

Compare SANW & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANW
  • CNSP
  • Stock Information
  • Founded
  • SANW 1980
  • CNSP 2017
  • Country
  • SANW United States
  • CNSP United States
  • Employees
  • SANW N/A
  • CNSP N/A
  • Industry
  • SANW Farming/Seeds/Milling
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SANW Consumer Staples
  • CNSP Health Care
  • Exchange
  • SANW Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • SANW 5.2M
  • CNSP 5.4M
  • IPO Year
  • SANW 2010
  • CNSP 2019
  • Fundamental
  • Price
  • SANW $2.23
  • CNSP $0.11
  • Analyst Decision
  • SANW
  • CNSP Strong Buy
  • Analyst Count
  • SANW 0
  • CNSP 1
  • Target Price
  • SANW N/A
  • CNSP $0.50
  • AVG Volume (30 Days)
  • SANW 20.0K
  • CNSP 41.4M
  • Earning Date
  • SANW 11-19-2024
  • CNSP 11-15-2024
  • Dividend Yield
  • SANW N/A
  • CNSP N/A
  • EPS Growth
  • SANW N/A
  • CNSP N/A
  • EPS
  • SANW N/A
  • CNSP N/A
  • Revenue
  • SANW $60,441,646.00
  • CNSP N/A
  • Revenue This Year
  • SANW $9.69
  • CNSP N/A
  • Revenue Next Year
  • SANW $53.85
  • CNSP N/A
  • P/E Ratio
  • SANW N/A
  • CNSP N/A
  • Revenue Growth
  • SANW N/A
  • CNSP N/A
  • 52 Week Low
  • SANW $2.10
  • CNSP $0.10
  • 52 Week High
  • SANW $14.25
  • CNSP $137.50
  • Technical
  • Relative Strength Index (RSI)
  • SANW 34.39
  • CNSP 37.06
  • Support Level
  • SANW $2.10
  • CNSP $0.10
  • Resistance Level
  • SANW $2.32
  • CNSP $0.13
  • Average True Range (ATR)
  • SANW 0.22
  • CNSP 0.02
  • MACD
  • SANW 0.05
  • CNSP 0.00
  • Stochastic Oscillator
  • SANW 17.81
  • CNSP 8.50

About SANW S&W Seed Company (NV)

S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. It produces approximately 500 650 seed products and has a sale in more than 40 30 countries. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: